The report aimed to identify key emerging drug targets of the future. It aimed to provide accurate predictions of emerging targets, in order to allow ITI Life Sciences to match future funded programmes to areas of increasing interest to the biotechnological (biotech) and pharmaceutical (pharma) community.
Methods
The methodology consisted of: consultations with key opinion leaders, pharma licensing directors, pharma and biotech research and development (R&D) executives, life sciences venture capital groups and drug identification service providers; an analysis of trends across the major classes of drug targets, using a trends analysis of publication rates; and an analysis of patent searches, including general patent applications and pharmaceutical composition patent applications.
Findings
The report finds that changing market conditions have led to an increased number of licensing deals for early stage (preclinical or PI) lead compounds. Identifying the key emerging drug targets would allow for the development of the necessary therapeutic lead compounds and supporting technologies that would generate valuable IP and assets. Identification of future emerging drug targets presents multiple opportunities for commercial exploitation along the way. The report finds that in-depth analysis of all potential molecular drug targets within each class and major classes of potential drug classes is challenging, so, instead, the research aimed to analyse trends across the major classes of drug targets. Using the example of RNAi, the report suggests that this kind of analysis may prove useful in unearthing technologies and emerging drug targets and guiding future investments. Based on this initial analysis, the report finds four target classes that fall within the definition of an emerging drug target field. Ubiquitin ligases and miRNA occupy an early stage opportunity, whereas Kinases and Nuclear Receptors both offer later stage opportunities that would require further definition.
Recommendations
The report suggests that these four emerging drug target classes warrant progression to an in-depth analysis which should include: an investigation of the selected target class, with a break down of the drivers, challenges and competition within the area; additional stratification to identify potential opportunities within the selected class; and an assessment of the Scottish fit. The report calls for dialogue with members of ITI Life Sciences group to ensure that the follow-up foresighting report is comprehensive and as rigorous as possible. ITI Life Sciences wished to engage with people with ideas for additional novel target classes (not individual molecules), as well as those involved in the identified target classes.
Cookies help Scottish Enterprise (“SE”, “us” or “we”) to provide you with a good experience when you browse our website and also allow us to improve our website. We assume that you are happy to receive all the cookies in the categories that you elect to allow, or which are strictly necessary for the operation of our website. You can change your cookie settings at any time.
Strictly necessary cookies
These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to log into secure areas of our website.
Cookie name
Purpose
Expiry
DS_SEC_Necessary_AllowedCookies
This cookie is used to record your preferences in regard to accepting marketing, performance or functionality cookies across the site.
1 year
se_session
This cookie is used to provide secure access to SE website features such as address lookup and form validation/submissions.
When browser is closed
Performance and analytics cookies
They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily.
Third party service
Purpose
Where to find out more
Google Analytics
Google Analytics helps us analyse the behaviour of users on our site, such as which pages they view, how long they spend on each page, and which elements they interact with.
Hotjar helps us analyse the behaviour of users on our site by collating data into heatmaps, scrollmaps and other visual representations. It also allows us to add short surveys to the site.
These cookies record your visit to our website, the pages you have visited and the links you have followed. We will use this information to make our website and the advertising displayed on it more relevant to your interests. We may also share this information with third parties for this purpose.
Third party service
Purpose
Where to find out more
Google Ads
By consenting to advertising we will share personal data with Google Ads to perform ad measurement services on our behalf, and that we obtain customer consent for such sharing and use where legally required. Google Ads help us to show pay per click ads in Google search results. These cookies help us track who comes to our site through these ads, so we know how successful they are. By granting permission for marketing cookies, you are confirming that you are happy to be tracked from our sites and receive targeted marketing based on your Google account details.
The LinkedIn Insight Tag helps us analyse the behaviour of visitors to our site who have come through LinkedIn adverts, and also helps us target advertising on LinkedIn.
Our website includes embedded videos from YouTube using YouTube’s Privacy-Enhanced Mode. This means YouTube will not store information or set cookies unless you play the video. When you press play, YouTube may set cookies on your device and collect information about your activity, which may be linked to your Google account if you are signed in. These cookies are managed by YouTube and are subject to Google’s Privacy Policy.
SE sometimes embeds photos and video content from websites such as YouTube and Flickr. As a result, when you visit a page with content embedded from, for example, YouTube or Flickr, you may be presented with cookies from these websites. SE does not control the dissemination of these cookies. You should check the relevant third party website for more information about these.
SE will not use cookies to collect personally identifiable information about you. However, if you wish to restrict or block the cookies which are set by SE websites, or any third party websites, you can do this through your browser settings. The Help function within your browser should tell you how.
Alternatively, you may wish to visit the About Cookies website, which contains comprehensive information about cookies and how to restrict or delete cookies on a wide variety of browsers.
Please be aware that restricting cookies may impact on the functionality of the SE website.
SE and our other websites use a number of suppliers who set cookies on our behalf in order to deliver the services that they are providing. We are constantly reviewing our use of cookies and, as such, this cookies policy will be regularly renewed to include up to date information about the cookies used by our suppliers. We would highly recommend that you check this page on a regular basis.
Further information
Our website carries embedded ‘share’ buttons to enable users of the site to easily share articles with their friends through a number of popular social networks. These sites may set a cookie when you are also logged in to their service. Scottish Enterprise does not control the dissemination of these cookies and you should check the relevant third party website for more information about these.
Similarly, Scottish Enterprise sometimes embeds photos and video content from websites such as YouTube and Flickr. As a result, when you visit a page with content embedded from, for example, YouTube or Flickr, you may be presented with cookies from these websites. Scottish Enterprise does not control the dissemination of these cookies. Again, you should check the relevant third party website for more information about these.
Scottish Enterprise will not use cookies to collect personally identifiable information about you. However, if you wish to restrict or block the cookies which are set by Scottish Enterprise websites, or any third party websites, you can do this through your browser settings. The Help function within your browser should tell you how.
Alternatively, you may wish to visit the About cookies opens in a new window website, which contains comprehensive information about cookies and how to restrict or delete cookies on a wide variety of browsers.
Please be aware that restricting cookies may impact on the functionality of the Scottish Enterprise website.
Scottish Enterprise and our other websites use a number of suppliers who set cookies on our behalf in order to deliver the services that they are providing. We are constantly reviewing our use of cookies and, as such, this cookies policy will be regularly renewed to include up to date information about the cookies used by our suppliers. We would highly recommend that you check this page on a regular basis.